Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial

Circulation - United States
doi 10.1161/01.cir.0000158485.70761.67
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention: Results of the Phase 2 Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Heparin Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2016English

Mean Platelet Volume in Patients Undergoing Percutaneous Coronary Intervention

Platelets
MedicineHematology
2013English

Predictors of Mortality in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Heart
2003English

Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Effect of Remote Ischemic Pre-Conditioning on Primary Percutaneous Coronary Intervention Outcomes: A Randomized Clinical Trial

Electronic physician
2019English

Percutaneous Coronary Intervention

2012English

Percutaneous Mechanical Circulatory Support Devices in High-Risk Patients Undergoing Percutaneous Coronary Intervention

Medicine
Medicine
2019English

Percutaneous Coronary Intervention

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy